| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/28/2006 | US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018797 Method for treating neurodegenerative disorders |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | WO2006029532A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | WO2006008133A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 03/23/2006 | WO2005120148A3 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 03/23/2006 | WO2004101507A3 N-sulphonylated amino acid derivatives and use thereof as matriptase inhibitors |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies |
| 03/23/2006 | CA2580131A1 Substituted aniline derivatives |
| 03/22/2006 | EP1636201A1 Para-substituted phenyl carbamates as inhibitors of hormone sensitive lipase |
| 03/22/2006 | EP1636200A2 Inhibitors of papilloma virus |
| 03/22/2006 | EP1636199A2 Method for the production of phenylacetic acid derivatives |
| 03/22/2006 | EP1636167A2 1-aminonaphthalenes as modulators of androgen, glucocorticoid, mineralocorticoid and progesterone receptors |
| 03/22/2006 | EP1635805A2 Sigma ligands for neuronal regeneration and functional recovery |
| 03/22/2006 | EP1635800A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/22/2006 | EP1020426B9 Amine derivatives and process for producing the same |
| 03/22/2006 | CN1749237A Tetra substituted chalcone derivative and preparing method and use |
| 03/22/2006 | CN1246300C Resorcinol derivatives |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015323 Resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds; for example, N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; use to treat inflammatory diseases for example |
| 03/21/2006 | US7015321 Synthesis of non-symmetrical sulfamides using burgess-type reagents |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015219 3-aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators |
| 03/21/2006 | CA2244140C Alkylated styrenes as prodrugs to cox-2 inhibitors |
| 03/21/2006 | CA2139112C Novel nicotinic acid esters |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/21/2006 | CA2043955C Pesticidal 1-arylpyrroles |
| 03/16/2006 | WO2006028161A1 Serotonin 5-ht3 receptor agonist |
| 03/16/2006 | WO2005115361A3 Androgen receptor modulators and method of treating disease using the same |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/16/2006 | US20060058294 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 03/16/2006 | US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 03/16/2006 | DE102004038107A1 Verfahren zur Verbesserung der Farbstabilität von Piperazin A method for improving the color stability of piperazine |
| 03/15/2006 | EP1634593A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634592A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1634591A2 Hypoglycemics comprising organic zinc (II) complexes |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633731A2 Thiocarbamate inhibitors of alpha-4 integrins |
| 03/15/2006 | EP1633702A1 Protease inhibitors |
| 03/15/2006 | EP1633701A1 Benzamide nitrile derivatives |
| 03/15/2006 | EP1633692A2 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 03/15/2006 | EP1633310A2 Thiotungstate analogues and uses thereof |
| 03/15/2006 | EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups |
| 03/15/2006 | EP1359891B1 Primary intermediates for oxidative coloration of hair |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | EP0934292B1 Metalloproteinase inhibitors |
| 03/15/2006 | CN1747930A Compounds having prolyl oligopeptidase inhibitory activity |
| 03/15/2006 | CN1747929A Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 03/15/2006 | CN1245394C Substituted phenylacetamides and their use as glucokinase activators |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/15/2006 | CN1245380C Anthranilic acid derivatives |
| 03/14/2006 | US7012153 Process for preparing benzoic acids |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/14/2006 | CA2155171C Preparation of amines |
| 03/14/2006 | CA2103838C Novel 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 03/09/2006 | WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 03/09/2006 | US20060052608 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis |
| 03/09/2006 | US20060052600 Amino-functional chalcones |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052445 Diarylsulfones as 5-HT2A antagonists |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052393 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | US20060052375 Bis-alkylbenzylamines |
| 03/09/2006 | US20060052372 N-(Heterocycloalkyl)alkylsulfonamides, e.g., N-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-N-(4-methoxyphenyl)-propanesulfonamide; improve blood flow to the optic nerve head and the retina ; used to treat retinal diseases, sleep disorders, depression, schizophrenia, anxiety, OCD, etc. |
| 03/09/2006 | US20060049061 electrooxidation reaction using 2-(N-pyrrolidine)-N,N,N-triethylethanammonium tetrafluoroborate or 3-N-piperidine-N,N,N-triethylammoniopropanesulphonamide tetrafluoroborate; proline final product |
| 03/09/2006 | CA2576830A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1631560A2 C-fms kinase inhibitors |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1039902B1 Inhibitors of gap junction communication |
| 03/08/2006 | CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity |
| 03/08/2006 | CN1244577C 4-phenyl-peiperazinyl,-piperidinyl and -tetrahydropyridyl derivatives |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 03/07/2006 | US7009078 halogenating in the 5-position and hydroxylating in the 4-position under lactonization, replacing halogen with azide, amidating lactone, then transferring the azide to the amine group |
| 03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | WO2006021655A2 Oxopiperidine derivatives, preparation and therapeutic use thereof |